login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
DECIPHERA PHARMACEUTICALS IN (DCPH) Stock News
USA
- NASDAQ:DCPH -
US24344T1016
-
Common Stock
25.59
USD
+0.02 (+0.08%)
Last: 6/10/2024, 8:00:00 PM
25.61
USD
+0.02 (+0.08%)
After Hours:
6/10/2024, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
DCPH Latest News, Press Relases and Analysis
All
Press Releases
a year ago - By: Brodsky & Smith LLC
- Mentions:
SQSP
AGS
RBAZ
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)
a year ago - By: Ono Pharmaceutical Co., Ltd.
Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono)
a year ago - By: Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet
2 years ago - By: Benzinga
Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)
a year ago - By: Brodsky & Smith LLC
- Mentions:
SQSP
AGS
RBAZ
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)
a year ago - By: Brodsky & Smith LLC
- Mentions:
RBAZ
SQSP
AGS
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)
1 years ago - By: Brodsky & Smith LLC
- Mentions:
SQSP
AGS
HCP
IBM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Squarespace, Inc. (NYSE – SQSP), PlayAGS, Incorporated (NYSE – AGS), HashiCorp Inc. (Nasdaq – HCP), Deciphera Pharmaceuticals, Inc. (Nasdaq – DCPH)
1 years ago - By: BusinessInsider
DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
1 years ago - By: InvestorPlace
DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
1 years ago - By: Brodsky & Smith LLC
- Mentions:
AGS
HCP
TBNK
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS, Incorporated (NYSE - AGS), HashiCorp Inc. (Nasdaq - HCP), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq - TBNK)
2 years ago - By: Kahn Swick & Foti, LLC
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH
2 years ago - By: Ono Pharmaceutical Co., Ltd.
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals
2 years ago - By: Brodsky & Smith LLC
- Mentions:
HCP
HTLF
TBNK
IBM
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HashiCorp Inc. (Nasdaq - HCP), Heartland Financial, USA Inc. (Nasdaq - HTLF), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq -
2 years ago - By: Benzinga
- Mentions:
PHG
ON
ANVS
ADXN
...
S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
2 years ago - By: InvestorPlace
- Mentions:
MULN
SHOP
BIDU
Why Is Mullen Automotive (MULN) Stock Up 27% Today?
2 years ago - By: InvestorPlace
- Mentions:
SHOP
BIDU
DPZ
Citi Just Raised Its Price Target on Shopify (SHOP) Stock
2 years ago - By: InvestorPlace
- Mentions:
DPZ
SOFI
TSLA
Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?
2 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Deciphera Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with ONO Pharmaceutical Co.
2 years ago - By: Investor's Business Daily
Deciphera Catapults 72% After Ono Pharmaceutical Agrees To Buy It For $2.4 Billion
2 years ago - By: Halper Sadeh LLC
DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders
2 years ago - By: Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
2 years ago - By: Purcell & Lefkowitz LLP
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)
Please enable JavaScript to continue using this application.